Mengis Capital Management’s Labcorp LH Stock Holding History

Mengis Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-976	Closed	-$213K	–	204
2024 Q1	$213K	Buy	+976	New	+$215K	0.03%	203

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mengis Capital Management's LH Position: Q2 2024 in Review

Mengis Capital Management sold out of Labcorp (LH) in Q2 2024, closing a stake of 976 shares — an estimated $213K sold.

Mengis Capital Management first reported a position in LH in Q1 2024 and held it in 1 quarter. The position peaked at $213K in Q1 2024. 852 funds tracked by Wall St. Rank hold LH as of Q2 2024.

Mengis Capital Management reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
Mengis Capital Management sold 976 Labcorp shares in Q2 2024, an estimated $213K.
Mengis Capital Management first reported a position in Labcorp in Q1 2024 and held it in 1 quarter.
Mengis Capital Management's Labcorp position peaked at $213K in Q1 2024.
852 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Mengis Capital Management's 13F filing for Q2 2024, filed 17 Jul 2024.